NDAORALTABLET, EXTENDED RELEASE
Approved
May 2016
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
Dipeptidyl Peptidase 4 Inhibitors
Pharmacologic Class:
Dipeptidyl Peptidase 4 Inhibitor
Loss of Exclusivity
LOE Date
Dec 8, 2037
143 months away
Patent Expiry
Dec 8, 2037
Exclusivity Expiry
Dec 20, 2026
Patent Records (5)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8883805 | Nov 26, 2025Expired | Product | — |
| 8883805*PED | May 26, 2026 | — | |
| 9173859 | May 4, 2027 | Product | U-1503 |
| 8673927 | May 4, 2027 | U-1503 | |
| 8673927*PED | Nov 4, 2027 | — |